Plain-English translation of NCT06112704 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 clinical trial testing , a new cancer treatment given as an intravenous infusion every three weeks. The trial aims to understand how well this medication works, how safe it is, and how your body processes it in patients with advanced esophageal cancer or other advanced solid tumors. The study is divided into two parts: the first part will test the medication in different types of esophageal cancer and other solid tumors, and the second part will focus specifically on one type of esophageal cancer.
Current treatments for advanced esophageal cancer and other solid tumors are limited, and doctors need new options to help patients. This trial is testing whether this medication can improve outcomes for people living with these hard-to-treat cancers.
You likely qualify if…
You likely don't qualify if…
You will receive as an intravenous infusion (drip into your vein) once every three weeks. The trial will involve multiple study visits at a cancer center where researchers will monitor how you are responding to the treatment and check for any side effects through blood tests and imaging scans. You will also need to provide tumor tissue and blood samples at the beginning of the study to help researchers understand how the medication affects your cancer. The trial is expected to involve regular visits over several months, with the exact duration depending on how you respond to treatment and whether side effects occur.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China